Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 5/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 1.00 |
| ▸ | CASP1 | P29466 | 2/20 | 1.00 |
| ▸ | CASP7 | P55210 | 2/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.44 |
| ▸ | MEN1 | O00255 | 3/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | RECQL | P46063 | 3/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | THRB | P10828 | 2/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | TNF | P01375 | 1/20 | 0.44 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.44 |
| ▸ | KDR | P35968 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL11775759 | 0.98 | TDP1 (0.96) | TDP1ALDH1A1HSD17B10CASP1CASP7 | |
| Ammonia Solution, Strong SCHEMBL11775754 | 0.98 | TDP1 (0.96) | TDP1ALDH1A1HSD17B10CASP1CASP7 | |
| SCHEMBL9454864 | 0.85 | ALDH1A1 (0.73) | TDP1ALDH1A1HSD17B10CASP1CASP7 | |
| SCHEMBL15449405 | 0.84 | TDP1 (0.72) | TDP1ALDH1A1HSD17B10CASP1CASP7 | |
| SCHEMBL17774563 | 0.83 | TDP1 (0.71) | TDP1ALDH1A1HSD17B10CASP1CASP7 | |
| SCHEMBL8747632 | 0.82 | ALDH1A1 (0.68) | TDP1ALDH1A1HSD17B10CASP1CASP7 | |
| SCHEMBL5546290 | 0.81 | HSD17B10 (0.68) | TDP1ALDH1A1HSD17B10CASP1CASP7 | |
| SCHEMBL13214335 | 0.80 | ALDH1A1 (0.67) | TDP1ALDH1A1HSD17B10CASP1CASP7 | |
| SCHEMBL17774713 | 0.80 | ALDH1A1 (0.64) | TDP1ALDH1A1HSD17B10CASP1CASP7 | |
| SCHEMBL25282372 | 0.79 | HSD17B10 (0.66) | TDP1ALDH1A1HSD17B10CASP1CASP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 191 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-3973911-A | FLUORESCENCE | UNIVERSITY OF ILLINOIS FOUNDATION (US) | 1976-08-10 | — | — | US | claimed |
| CN-107012695-B | Penetrating fluid for ink jet textile printing, ink jet textile printing method, and ink jet textile printing apparatus | 精工爱普生株式会社 | 2020-08-07 | — | — | CN | disclosed |
| US-10190009-B2 | Ink composition, ink jet recording method using same, and colored material | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2019-01-29 | — | — | US | disclosed |
| US-9872822-B2 | Process for dyeing in the presence of oxidation bases comprising at least one sulfonic, sulfonamide, sulfone, amid or acid group and a metal catalyst, device and ready-to-use composition | L'OREAL (FR) | 2018-01-23 | — | — | US | disclosed |
| US-9872822-B2 | Process for dyeing in the presence of oxidation bases comprising at least one sulfonic, sulfonamide, sulfone, amid or acid group and a metal catalyst, device and ready-to-use composition | L'OREAL (FR) | 2018-01-23 | — | — | US | disclosed |
| EP-2441806-B1 | PORPHYRAZINE COLORING MATTER, INK COMPOSITION, RECORDING METHOD, AND COLORED OBJECT | NIPPON KAYAKU KK (JP) | 2017-09-06 | — | — | EP | disclosed |
| US-9745336-B2 | Fluorescent dye compounds, conjugates and uses thereof | APPLIED BIOSYSTEMS, LLC (US) | 2017-08-29 | — | — | US | disclosed |
| EP-2463345-B1 | Ink composition, recording method using the same and recorded material | SEIKO EPSON CORP (JP) | 2017-01-18 | — | — | EP | disclosed |
| US-20160160065-A1 | INK COMPOSITION, INK JET RECORDING METHOD USING SAME, AND COLORED MATERIAL | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2016-06-09 | — | — | US | disclosed |
| US-20160143826-A1 | PROCESS FOR DYEING IN THE PRESENCE OF OXIDATION BASES COMPRISING AT LEAST ONE SULFONIC, SULFONAMIDE, SULFONE, AMID OR ACID GROUP AND A METAL CATALYST, DEVICE AND READY-TO-USE COMPOSITION | L'OREAL (FR) | 2016-05-26 | — | — | US | disclosed |
| EP-0142104-A2 | Fibre-reactive chromium complexes, their preparation and their use | CIBA-GEIGY AG (CH) | 1985-05-22 | — | — | EP | disclosed |
| EP-0130549-A2 | 5-Aminosalicylic acid-0-sulfates of physiologically acceptable bases, process for their production and medicines containing them | Henning Berlin GmbH Chemie und Pharmawerk (DE) | 1985-01-09 | — | — | EP | disclosed |
| US-4283331-A | FIBER-REACTIVE DYES | CIBA-GEIGY CORPORATION (US) | 1981-08-11 | — | — | US | disclosed |
| US-4159384-A | COMPLEMENT INHIBITORS | AMERICAN CYANAMID COMPANY (US) | 1979-06-26 | — | — | US | disclosed |
| US-4123455-A | COMPLEMENT INHIBITORS | AMERICAN CYANAMID COMPANY (US) | 1978-10-31 | — | — | US | disclosed |
| US-4102918-A | Anionic phenylcarboxamide complement inhibitors | AMERICAN CYANAMID COMPANY (US) | 1978-07-25 | — | — | US | disclosed |
| US-4001205-A | WATER-SOLUBLE, FIBER-REACTIVE PHENYLAZODIHYDROXY, METHYL, CYANOPYRIDINE DYESTUFFS | CIBA-GEIGY AG (CH) | 1977-01-04 | — | — | US | disclosed |
| US-3973911-A | FLUORESCENCE | UNIVERSITY OF ILLINOIS FOUNDATION (US) | 1976-08-10 | — | — | US | disclosed |
| US-3973911-A | FLUORESCENCE | UNIVERSITY OF ILLINOIS FOUNDATION (US) | 1976-08-10 | — | — | US | disclosed |
| US-3956263-A | 4-Methyl-2,6-dihydroxy-3-cyanopyridine containing dyestuffs | CIBA-GEIGY AG (CH) | 1976-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160143826-A1 | PROCESS FOR DYEING IN THE PRESENCE OF OXIDATION BASES COMPRISING AT LEAST ONE SULFONIC, SULFONAMIDE, SULFONE, AMID OR ACID GROUP AND A METAL CATALYST, DEVICE AND READY-TO-USE COMPOSITION | KRT18, ARSA, SQOR | TDP1 3636/4885ALDH1A1 440/4885HSD17B10 529/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.